Results 101 to 110 of about 711,937 (246)

A case of developing progressive multifocal leukoencephalopathy while using rituximab and mycophenolate mofetil in refractory systemic lupus erythematosus

, 2018
Yuichi Ishikawa, Tadamichi Kasuya, Junichi Ishikawa, Michio Fujiwara, Yasuhiko Kita Department of Rheumatology, Yokohama Rosai Hospital, Kohoku-ku, Yokohama, Kanagawa, Japan Abstract: Progressive multifocal leukoencephalopathy (PML) is a central ...
Fujiwara M, Ishikawa Y, Ishikawa J, Kita Y, Kasuya T   +4 more
core  

Immune profiling of a patient with alemtuzumab-associated progressive multifocal leukoencephalopathy

Multiple Sclerosis, 2019
A 31-year-old woman affected by multiple sclerosis (MS) experienced generalized tonic–clonic seizures 2 months after the second alemtuzumab cycle. Positive JC virus (JCV)-DNA in cerebrospinal fluid (CSF) and lesion iconography at magnetic resonance ...
S. Gerevini, R. Capra, D. Bertoli, A. Sottini, L. Imberti   +4 more
semanticscholar   +1 more source

What is the risk of progressive multifocal leukoencephalopathy in patients with ulcerative colitis or Crohn’s Disease treated with vedolizumab? [PDF]

, 2018
Background: Progressive multifocal leukoencephalopathy is a serious condition linked to certain diseases and immunosuppressant therapies, including the α4 integrin antagonist natalizumab.
Card, Timothy R., Liang, Huifang, Xu, Jing, Jing Xu, Timothy Card, Huifang Liang, Fatima Bhayat, Bhayat, Fatima   +7 more
core   +1 more source

Human Polyomavirus JCPyV and Its Role in Progressive Multifocal Leukoencephalopathy and Oncogenesis

Frontiers in Oncology, 2019
The human neurotropic virus JCPyV, a member of the Polyomaviridiae family, is the opportunistic infectious agent of Progressive Multifocal Leukoencephalopathy (PML), a fatal disease seen in severe immunosuppressive conditions and, during the last decade,
L. Del Valle, S. Piña-Oviedo
semanticscholar   +1 more source

Progressive Multifocal Leukoencephalopathy in a Kidney Transplant Recipient

Turkish Journal of Nephrology
Cite this article as: Tahillioglu Y, Mirioglu S, Ucar AR, et al. Progressive multifocal leukoencephalopathy in a kidney transplant recipient. Turk J Nephrol. 2026;35(3):256-257.
Yağmur Tahıllıoğlu, Şafak Mirioğlu, Ali Rıza Uçar, Ahmet Burak Dirim, Murat Kürtüncü, Aydın Türkmen, Halil Yazıcı   +6 more
doaj   +1 more source

A Representative Survey of M.S. Patients on Attitudes toward the Benefits and Risks of Drug Therapy [PDF]

Background: Although M.S. patients face significant trade-offs between risks and benefits of drug therapy, little is known of their attitudes toward these risks and benefits.
Calfee, John E.
core  

Progressive multifocal leukoencephalopathy - the importance of early diagnosis illustrated in four cases.

, 2008
Progressive multifocal leukoencephalopathy (PML) is a rare, deadly demyelinating disease of the central nervous system, which is caused by a reactivation of the DNA polyomavirus JC and occurs in immunosuppressed individuals.
Nived, Ola, Jönsen, Andreas, Bengtsson, Anders, Sturfelt, Gunnar   +3 more
core   +1 more source

Design and Validation of 2nd Gen. Anti-JCV TCR Constructs for Progressive Multifocal Leukoencephalopathy Immunogene Therapy

, 2022
Design and Validation of 2nd Gen.
Anthony J Bais (13285305)
core   +1 more source

Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency

Neurology: Neuroimmunology & Neuroinflammation, 2019
Progressive multifocal leukoencephalopathy (PML) is a devastating demyelinating disease of the CNS, which develops almost exclusively in immunocompromised patients and is caused by JC virus (JCV), a common polyomavirus.1 So far, treatment efficacy is ...
Clemens Küpper, Johanna Heinrich, K. Kamm, V. Bücklein, S. Rothenfusser, A. Straube   +5 more
semanticscholar   +1 more source

Susceptibility-Weighted MR Imaging Hypointense Rim in Progressive Multifocal Leukoencephalopathy: The End Point of Neuroinflammation and a Potential Outcome Predictor

American Journal of Neuroradiology, 2019
This retrospective study included 18 patients with a definite diagnosis of progressive multifocal leukoencephalopathy. Ten patients were HIV-positive, 3 patients had natalizumab-associated PML, 1 patient had multiple myeloma, 3 patients had a history of ...
M. Thurnher, J. Boban, A. Rieger, E. Gelpí   +3 more
semanticscholar   +1 more source